BRPI0520622A2 - processo para o preparo de conjugados de insulina - Google Patents
processo para o preparo de conjugados de insulinaInfo
- Publication number
- BRPI0520622A2 BRPI0520622A2 BRPI0520622-7A BRPI0520622A BRPI0520622A2 BR PI0520622 A2 BRPI0520622 A2 BR PI0520622A2 BR PI0520622 A BRPI0520622 A BR PI0520622A BR PI0520622 A2 BRPI0520622 A2 BR PI0520622A2
- Authority
- BR
- Brazil
- Prior art keywords
- insulin
- oligomer
- precursor
- conjugate
- insulin conjugates
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 abstract 3
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000001851 biosynthetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROCESSO PARA O PREPARO DE CONJUGADOS DE INSULINA. A presente invenção refere-se a um processo para produção de IN-1 05, conjugado insulina-oligómero. O precursor da IN-105 tendo a fórmula G-A-V-R-[Cadeia B]-R-D-A-D-D-R-[Cadeia A] é clonado e expresso em Píchia. O precursor biossintético é, em seguida, conjugado a um oligómero ativado. O conjugado precursor da IN-105-oíigómero é tratado, em seguida, com protease e purificado para dar origem ao conjugado ativo insulina-oligómero da fórmula insulina-OC-CH~ 2~-CH~ 2~-(OCH~ 2~CH~ 2~)~ 3~-OCH~ 3~.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2005/000338 WO2007043059A1 (en) | 2005-10-13 | 2005-10-13 | Process for the preparation of insulin conjugates. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0520622A2 true BRPI0520622A2 (pt) | 2009-05-19 |
| BRPI0520622B1 BRPI0520622B1 (pt) | 2021-04-13 |
| BRPI0520622B8 BRPI0520622B8 (pt) | 2021-05-25 |
Family
ID=37942365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0520622A BRPI0520622B8 (pt) | 2005-10-13 | 2005-10-13 | processo para o preparo de conjugados de insulina |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8058391B2 (pt) |
| EP (1) | EP1934252B1 (pt) |
| JP (1) | JP5047978B2 (pt) |
| KR (1) | KR101269540B1 (pt) |
| CN (1) | CN101291952B (pt) |
| BR (1) | BRPI0520622B8 (pt) |
| DK (1) | DK1934252T3 (pt) |
| ES (1) | ES2546016T3 (pt) |
| IL (1) | IL190666A (pt) |
| MX (1) | MX2008004674A (pt) |
| PL (1) | PL1934252T3 (pt) |
| PT (1) | PT1934252E (pt) |
| WO (1) | WO2007043059A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11361853B2 (en) | 2002-10-29 | 2022-06-14 | Practice Velocity, LLC | Method and system for automated medical records processing with telemedicine |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| US7989160B2 (en) | 2006-02-13 | 2011-08-02 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| WO2008049711A1 (en) | 2006-10-27 | 2008-05-02 | Novo Nordisk A/S | Peptide extended insulins |
| BRPI0822775A2 (pt) * | 2008-02-19 | 2015-06-30 | Biocon Ltd | Método de obtenção de uma proteína heteróloga, purificada, biologicamente ativa. |
| RU2458989C1 (ru) * | 2008-08-07 | 2012-08-20 | Байокон Лимитид | Способ получения аналогов инсулина из их соответствующих предшественников (варианты) |
| CN102471367A (zh) * | 2009-07-09 | 2012-05-23 | 拜康有限公司 | 一种制备非线性梯度色谱法及其纯化的产物 |
| AR080884A1 (es) | 2010-04-14 | 2012-05-16 | Sanofi Aventis | Conjugados de insulina-sirna |
| US9457096B2 (en) | 2012-07-06 | 2016-10-04 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery |
| ES2723885T3 (es) | 2012-07-19 | 2019-09-03 | Daiichi Sankyo Co Ltd | Anticuerpos anti-Siglec-15 |
| SE539197C2 (en) * | 2015-09-15 | 2017-05-09 | Nida Tech Sweden Ab | Positioning system and device comprising an electronic ink display |
| EP3405785B1 (en) * | 2016-01-23 | 2020-04-29 | Biocon Limited | Bio-analytical method for insulin analogues |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
| IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
| US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5321095A (en) * | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
| IT1291623B1 (it) * | 1997-04-18 | 1999-01-11 | Bracco Spa | Procedimento per la coniugazione di chelanti con molecole contenenti gruppi amminici |
| JP3406244B2 (ja) * | 1999-04-30 | 2003-05-12 | 伊藤ハム株式会社 | 新規な融合蛋白質からの組み換えインスリンの製造方法 |
| US6309633B1 (en) | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| US6828297B2 (en) * | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| DE60234198D1 (de) | 2001-09-07 | 2009-12-10 | Biocon Ltd | Verfahren zur synthese von insulinpolypeptid-oligomer-konjugaten und proinsulinpolypeptid-oligomer-konjugaten und verfahren zu deren synthese |
| US6770625B2 (en) * | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
| US7312192B2 (en) | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| US20060035316A1 (en) * | 2002-11-12 | 2006-02-16 | Sang-Yong Lee | Plasmids expressing human insulin and the preparation method for human insuling thereby |
| DK1660047T3 (en) * | 2003-08-13 | 2014-03-10 | Biocon Ltd | MICROPARTICALLY FATIC ACID SALT SOLID DOSAGE FORMS FOR THERAPEUTIC AGENTS |
| ATE496941T1 (de) * | 2005-07-08 | 2011-02-15 | Biocon Ltd | Herstellung von insulinkonjugaten |
-
2005
- 2005-10-13 BR BRPI0520622A patent/BRPI0520622B8/pt not_active IP Right Cessation
- 2005-10-13 DK DK05813799.3T patent/DK1934252T3/en active
- 2005-10-13 PL PL05813799T patent/PL1934252T3/pl unknown
- 2005-10-13 PT PT58137993T patent/PT1934252E/pt unknown
- 2005-10-13 KR KR1020087009648A patent/KR101269540B1/ko active IP Right Grant
- 2005-10-13 WO PCT/IN2005/000338 patent/WO2007043059A1/en active Application Filing
- 2005-10-13 EP EP05813799.3A patent/EP1934252B1/en active Active
- 2005-10-13 US US12/083,275 patent/US8058391B2/en active Active
- 2005-10-13 MX MX2008004674A patent/MX2008004674A/es active IP Right Grant
- 2005-10-13 CN CN200580051831.0A patent/CN101291952B/zh not_active Expired - Fee Related
- 2005-10-13 JP JP2008535192A patent/JP5047978B2/ja not_active Expired - Fee Related
- 2005-10-13 ES ES05813799.3T patent/ES2546016T3/es active Active
-
2008
- 2008-04-07 IL IL190666A patent/IL190666A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP5047978B2 (ja) | 2012-10-10 |
| WO2007043059A1 (en) | 2007-04-19 |
| CN101291952A (zh) | 2008-10-22 |
| PL1934252T3 (pl) | 2015-10-30 |
| EP1934252B1 (en) | 2015-06-24 |
| MX2008004674A (es) | 2008-11-12 |
| BRPI0520622B8 (pt) | 2021-05-25 |
| IL190666A (en) | 2014-08-31 |
| DK1934252T3 (en) | 2015-08-31 |
| EP1934252A4 (en) | 2010-07-14 |
| CN101291952B (zh) | 2016-02-03 |
| PT1934252E (pt) | 2015-10-12 |
| ES2546016T3 (es) | 2015-09-17 |
| KR101269540B1 (ko) | 2013-05-30 |
| EP1934252A1 (en) | 2008-06-25 |
| JP2009511039A (ja) | 2009-03-19 |
| IL190666A0 (en) | 2008-11-03 |
| US20110020871A1 (en) | 2011-01-27 |
| BRPI0520622B1 (pt) | 2021-04-13 |
| KR20080067625A (ko) | 2008-07-21 |
| US8058391B2 (en) | 2011-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0520622A2 (pt) | processo para o preparo de conjugados de insulina | |
| MXPA05009384A (es) | Procedimiento para la preparacion de derivados de topiramato anticonvulsivos. | |
| BR0316375A (pt) | Diazinopirimidinas | |
| AR058592A1 (es) | Vacuna | |
| WO2007113224A3 (en) | Conjugation process for pnag and a carrier protein | |
| BRPI0514841A (pt) | inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores | |
| ES2133614T3 (es) | Derivados de propiofenona y procedimiento para su preparacion. | |
| BRPI0409716A (pt) | derivados de 2-acilamino-4-feniltiazol, seu preparo e sua aplicação em terapêutica | |
| TW200716203A (en) | Manufacturing process for tigecycline | |
| UA100367C2 (uk) | Спосіб одержання мемантину і його гідрохлориду | |
| MX2008008120A (es) | Nuevos compuestos y metodos para formar taxanos y uso de los mismos. | |
| TW200504009A (en) | Novel diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | |
| IL188603A0 (en) | Preparation of insulin conjugates | |
| BR0115036A (pt) | Processo para a preparação de um composto | |
| DK1327146T3 (da) | Forbindelse med et forgrenet linkermolekyle | |
| BR0008682A (pt) | 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento | |
| WO2009150543A3 (en) | Conjugated vi saccharides | |
| BR0011028A (pt) | Agentes anestésicos dérmicos | |
| BR0112598A (pt) | Processo para a preparação de (r,s)-axetil cefuroxima cristalina de alta pureza | |
| BR0205062A (pt) | Spandex e processo para produzir spandex | |
| BR0211514A (pt) | Processo para produção de beraprost e seus sais | |
| PT1272495E (pt) | Processo para a preparacao de cefoperazona de sodio altamente cristalina | |
| GB9920959D0 (en) | Novel process | |
| BR0315892A (pt) | Processo contìnuo para a preparação de derivados de sulfamato de frutopiranose | |
| BR0213329A (pt) | Processo para preparação de 14beta-hidróxi-baccatin iii-1,14carbonato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001 |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2744 DE 08-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |